Author: Tom Wilemon
Dec. 5, 2023—Vanderbilt’s Eden Biltibo, MD, MS, is one of the first recipients of the Multiple Myeloma Research Foundation’s Scholars Program, an initiative launched in 2022.
Nov. 30, 2023—A group of Ukrainian oncologists recently visited Vanderbilt-Ingram Cancer Center where they toured research labs, observed tumor board meetings, met with several Vanderbilt oncologists, and attended the 23rd Annual Retreat for Cancer Biology.
Oct. 26, 2023—Internationally recognized cancer survivorship expert Debra Friedman, MD, MS, has been named deputy director of Vanderbilt-Ingram Cancer Center
Oct. 17, 2023—Vanderbilt-Ingram Cancer Center has earned a Merit Extension Award from the National Cancer Institute in recognition of more than a decade of sustained exceptional progress.
Oct. 12, 2023—Vanderbilt University Medical Center Department of Urology and Vanderbilt-Ingram Cancer Center are hosting a symposium for prostate cancer survivors and their families on Saturday, Nov. 11.
Symposium for patients, caregivers and family members offers important information on stomach cancer, Nov. 4
Oct. 12, 2023—A Vanderbilt symposium on Nov. 4 offers detailed information for patients, caregivers and family members about stomach cancer.
Oct. 5, 2023—A Vanderbilt study found that a drug that has been used for decades for intestinal pinworms, can be repurposed as a preventative treatment for stomach cancer.
Oct. 4, 2023—Vanderbilt researchers have discovered a druggable target on natural killer cells that could potentially trigger a therapeutic response in patients with immunotherapy-resistant, triple-negative breast cancer.
Sep. 12, 2023—Vanderbilt researchers at have found new genes that put people at higher risk for colon cancer and rectal cancer.
Sep. 1, 2023—The Robert J. Kleberg, Jr. and Helen C. Kleberg Foundation has funded an ambitious initiative to overcome one of the most perplexing and frustrating mysteries of cancer treatment — how to prevent drug resistance.
Aug. 17, 2023—Vanderbilt-Ingram Cancer Center recently hosted the first of a planned series of events to highlight the diversity of oncology researchers and to nurture networking opportunities for them.
Aug. 10, 2023—Seven new leaders have been appointed to guide Vanderbilt-Ingram Cancer Center’s research programs.